NEW YORK (GenomeWeb) – Rennova Health said today that it has acquired the 85 percent stake in pharmacogenetics testing firm Genomas that it did not already own.

Hartford, Connecticut-based Genomas has developed and offers the PhyzioType System for DNA-guided management and prescription of drugs used to treat mental illness, pain, heart disease and diabetes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.